Ezrin links cortical actin filaments with the cell membrane, and has a critical role in many membrane-initiated events. Fas is directly associated with ezrin, but conflicting results have been reported for the involvement of ezrin in Fas-induced cell death. In this study we show that ezrin was associated with Fas in T cells before stimulation and was released shortly after Fas ligand (FasL) engagement. The knockdown of ezrin moderately increased Fastriggered or tumor necrosis factor-related apoptosisinducing ligand (TRAIL)-triggered cell death in normal T lymphocytes and in H9 cells, but had no effect on death receptor-induced apoptosis in type II cells, such as Jurkat and CEM. Expression of a dominant-negative form of ezrin also led to an increased Fas-induced apoptosis in H9 cells. Ezrin deficiency did not affect the internalization of Fas after Fas ligation. Instead, an enhanced formation of death-inducing signaling complex (DISC) was observed in H9 cells with ezrin knockdown, leading to accelerated caspase-8 activation. Together, our results suggest that ezrin has a negative role in the recruitment of Fas into signaling complexes in type I T cells. Loss of ezrin likely removes the constraint imposed by ezrin and facilitates the assembly of death receptor complex in T cells.
Introduction
Ezrin, radixin and moesin (ERM) are proteins controlling the linkage between cortical actin filaments and membrane proteins (Bretscher et al., 2002; Gautreau et al., 2002; Niggli and Rossy, 2008) . ERM are activated by phosphorylation at the C-terminal threonine or by the binding of phosphatidylinositol 4,5-biphosphate (PIP2) (Bretscher et al., 2002; Niggli and Rossy, 2008; Belkina et al., 2009) . Activated ERM proteins bind directly to the cortical actin cytoskeleton. Dephosphorylation of the C-terminal threonine and reduction in phosphatidylinositol 4,5-biphosphate levels lead to inactivation of ERM and their release from the cell membrane . Ezrin and moesin are the major ERM proteins in T lymphocytes (Shcherbina et al., 1999) , and participate in cell functions in either an activated or an inactivated form. Activated ezrin and moesin are required for the formation of the distal pole complex (Allenspach et al., 2001) and for the movement of a cytotoxic cell to target cells (Mrass et al., 2008) . Alternatively, lymphocyte activation and remolding involves ezrin/moesin inactivation and dissociation from cortical actin (Delon et al., 2001; Brown et al., 2003; Faure et al., 2004; Gupta et al., 2006) .
Fas (CD95)-induced cell death starts from formation of sodium dodecyl sulfate-resistant Fas microaggregates, followed by the formation of death-inducing signaling complexes (DISCs) containing Fas-associated protein with death domain (FADD), procaspase-8 and cellular-FLICE inhibitory protein (c-FLIP) (Nagata, 1997; Algeciras-Schimnich et al., 2002; Peter and Krammer, 2003; Peter et al., 2007; Strasser et al., 2009) . The processing of pro-caspase-8 to caspase-8 in DISC leads to the activation of effector caspases and eventual cell death. Depending on the amount of DISC formation, Fas-sensitive cells are divided into type I and type II (Scaffidi et al., 1998) . In type I cells, Fas forms sodium dodecyl sulfate-resistant high-order aggregates, followed by rapid internalization of Fas and DISC formation (Algeciras-Schimnich et al., 2002; Lee et al., 2006; Chakrabandhu et al., 2007; Feig et al., 2007) . In type II cells, a very limited amount of DISC is formed and apoptotic signaling needs amplification through mitochondria (Scaffidi et al., 1998) .
Fas is directly associated with ezrin (Parlato et al., 2000; Lozupone et al., 2004; He´bert et al., 2008) , but the requirement for ezrin and actin filament in Fas-triggered cell death remains controversial. A study by Kondo et al. (1997) showed that dephosphorylation of ERM proteins and translocation of ERM into cytoplasm is essential for Fas-induced apoptosis to proceed. Dephosphorylation of ERM in activated T cells also confers a susceptibility to Fas-mediated apoptosis (Ramaswamy et al., 2007) . Consistent with these observations, disruption of the actin cytoskeleton enhances the clustering of Fas (Kulms et al., 2002) . These results support the notion that the inactivation of ezrin and its release into the cytosol are associated with Fas-induced apoptosis. Alternatively, the interaction of Fas with ezrin and actin cytoskeleton is also suggested to be required for the initiation of Fasmediated apoptosis. Fas is associated with ezrin in T cells that are sensitive to Fas-induced apoptosis, but not in T cells that are resistant to Fas-triggered death (Parlato et al., 2000) . The downregulation of ezrin in CEM cells abolishes their susceptibility to Fas-induced apoptosis (Parlato et al., 2000) , and the knockdown of ezrin or moesin in Jurkat cells decreases Fas-triggered apoptosis (He´bert et al., 2008) . It has also been shown that Fasezrin-actin linkage is involved in Fas endocytosis, and Fas-induced apoptosis was attenuated in ezrin-knockdown L12.10 cells (Chakrabandhu et al., 2007 (Chakrabandhu et al., , 2008 . Therefore, the exact role of ezrin in death receptorinitiated apoptosis remains unsettled.
In this study, we analysed the role of ezrin in Fasinduced apoptosis in T lymphocytes. We found that the knockdown of ezrin by small interfering RNA (siRNA) did not interfere with Fas-triggered cell death in type II cells, but moderately enhanced Fas-induced apoptosis in normal T cells and type I cells. Ezrin was not required for the endocytosis of Fas in type I T cells. The increase in Fas-mediated cell death in ezrin-deficient cells could be partly attributed to increased DISC formation. Our results suggest that the removal of ezrin leads to enhanced Fas-induced DSIC formation and apoptosis in type I T lymphocytes.
Results

Dissociation of ezrin from death receptor after Fas ligand (FasL) engagement
To analyse the function of ezrin in Fas-mediated apoptosis, we re-examined the interaction between ezrin and Fas. Similar to previous reports (Parlato et al., 2000; Lozupone et al., 2004) , recombinant ezrin bound directly to Fas in a glutathione S-transferase (GST) pull-down assay (Figure 1a) . The association of ezrin with Fas during the course of Fas-mediated apoptosis was also monitored in H9 cells, a type I cell line known for prominent DISC formation (Scaffidi et al., 1998; Algeciras-Schimnich et al., 2002; Lee et al., 2006) . Ezrin was associated with Fas in H9 cells before treatment (Figure 1b) . Stimulation with FasL led to the recruitment of FADD and pro-caspase-8 to Fas, as well as the processing of pro-caspase-8. Interestingly, FasL ligation also led to the dissociation of ezrin from Fas-activating complex; despite a very small amount of ezrin remaining detectable, the majority of Fas-associated ezrin was released within 20 min ( Figure 1b) . We also monitored the phosphorylation of ezrin after FasL ligation. Consistent with the reports of Kondo et al. (1997) , ezrin phosphorylation was diminished after FasL treatment (Figure 1c ), suggesting that ezrin inactivation were treated with FLAG-FasL (50 ng/ml) for the indicated time, lysed, and cell lysates were precipitated with FLAG-M2 beads. The associated ezrin, pro-caspase-8, Fas-associated protein with death domain (FADD) levels were determined using immunoblotting. Input indicates the level of the given protein in lysates. (c, d) Early dephosphorylation and late re-phosphorylation of ezrin after FasL treatment. H9 cells were treated with FLAG-FasL and cell lysates prepared at the indicated time points. The levels of ezrin, phospho-ezrin (Thr567) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were determined by western blots using the appropriate antibodies.
Deficiency in ezrin enhances Fas-induced apoptosis W-C Kuo et al is accompanied with Fas DISC assembly. It should be noted that prolonged FasL stimulation (>25 min) led to increased phosphorylation of ezrin-moesin (Figures 1c  and d ), in accordance with earlier reports (He´bert et al., 2008) .
Enhanced Fas-and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell death in ezrin-deficient H9 cells Because both ezrin phosphorylation and ezrin association were reduced early on in the Fas-triggered apoptotic process, we analysed whether ezrin was required for Fas-mediated cell death in H9 cells. Ezrin was effectively downregulated in H9 cells using a lentiviral vector carrying ezrin-specific short hairpin RNA (shRNA; Figure 2a ). The knockdown of ezrin in H9 cells led to a nearly twofold increase in Fasmediated apoptosis triggered by CH11, relative to the control H9 cells (Figure 2b) . A similar extent of increased cell death in ezrin-knockdown H9 cells was found with FasL or Apo-1 treatment (data not shown). In addition, TRAIL-triggered cell death was also substantially enhanced in ezrin-deficient H9 cells (Figure 2c ). The profound effect of ezrin knockdown on death receptor-induced apoptosis in H9 cells was specific for ezrin. The downregulation of moesin ( Figure 2a ) had no effect on CH11-triggered cell death in H9 cells (Figure 2d ). Therefore, ezrin is not required for, but instead is a negative regulator of, death receptor-induced apoptosis in H9 cells.
Downregulation of ezrin moderately increases
Fas-triggered apoptosis in normal T lymphocytes The finding that ezrin has a negative role in Fas-induced cell death in H9 cells led us to further examine the effect of ezrin knockdown in Fas-mediated apoptosis in normal T cells. Peripheral blood T cells were activated by anti-CD3/ CD28 for 2 days, maintained in interleukin-2 for another 3 days and then transfected with ezrin-specific siRNA. Figure 3a illustrates that ezrin levels were reduced by more than 90% in normal T cells by specific hairpin siRNA, but not by a control Cy3-labelled siRNA. In normal T cells with ezrin-knockdown, apoptosis triggered by FasL or CH11 was also moderately increased relative to the control siRNA-transfected T cells (Figures 3b  and c) . The enhancement in Fas-induced cell death caused by ezrin downregulation in normal T cells was not as profound as in H9 cells, which may reflect some difference between the normal and transformed T cells.
Enhanced apoptosis in H9 cells expressing ezrin dominant-negative mutant
To ensure that the effect of ezrin knockdown was not due to the downregulation of some unknown off-target mechanism, we overexpressed a dominant-negative form of ezrin, ezrin (1-320), in H9 cells. This dominant-negative ezrin promotes the dissociation of ezrin from actin filaments, and has been used to evaluate the requirement of ezrin in specific biological events. Ezrin(1-320)-Myc was transduced into H9 cells by retroviral infection, and its expression confirmed using anti-Myc antibodies ( Figure 4a ). Expression of the dominant-negative form of ezrin in H9 cells also increased (Figures 2-4) . To analyse whether ezrin may have opposite roles in type I (H9) and type II (Jurkat and CEM) T cells, we also studied the effect of ezrin knockdown in death receptormediated apoptosis in both Jurkat and CEM cells. Ezrin was knocked down in Jurkat by transfection with hairpin siRNA specific for ezrin. Figure 5a illustrates more than 90% reduction in ezrin levels in Jurkat cells up to 72 h after transfection with ezrin siRNA. FasLinduced apoptosis was determined in Jurkat cells at 48 h after siRNA transfection, and the extent of cell death in ezrin-knockdown and control Jurkat cells was nearly identical (Figure 5b ). CH11-induced or Apo1-3-induced apoptosis was also similar in both ezrin-deficient and control Jurkat cells (Figures 5c and d) . In addition, TRAIL-triggered cell death in Jurkat cells was not altered by ezrin deficiency (not shown). Ezrin was also knocked down in CEM cells by infection with pLL3.7- /ml) were treated with Fas ligand (FasL; 150 ng/ml), cell lysates were prepared at the indicated time points and the levels of procaspase-8, active caspase-8, pro-caspase-3 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were determined using western blots. **Po0.01; ***Po0.001. (Supplementary Figure 2a) . In this study, the downregulation of ezrin did not affect cell death in CEM cells triggered by FasL or CH11 (Supplementary Figure 2b , data not shown for CH11). Contrary to the reports that ezrin reduction impaired Fas-induced apoptosis (Parlato et al., 2000; He´bert et al., 2008) , Fas-mediated apoptosis was not affected in Jurkat and CEM cells that were deficient in ezrin. In a separated experiment, overexpression of wild-type ezrin in Jurkat cells did not affect FasL-triggered apoptosis (Supplementary Figures 1c and d) . Therefore, death receptorinduced cell death in type II cells is ezrin independent.
Deficiency in ezrin enhances
Normal Fas endocytosis in ezrin-deficient H9 cells after Fas engagement Another reported function of ezrin is its involvement in the endocytosis of Fas that is essential for DISC formation and the activation of caspase-8 (Lee et al., 2006; Chakrabandhu et al., 2007) . We analysed whether the internalization of Fas was affected by ezrin deficiency in H9 cells. The surface Fas levels in H9 cells after Fas ligation were monitored. Figure 6a illustrates that antiFas treatment led to a time-dependent disappearance of Fas from the cell surface in the control H9 cells. The knockdown of ezrin did not affect either the extent or the kinetics of Fas endocytosis (Figure 6b ), suggesting that Fas internalization is not dependent on ezrin in H9 cells.
Accelerated caspase-8 cleavage and increased deathinducing signaling complex (DISC) formation in ezrin-deficient H9 cells We examined the expression of components that were immediately downstream of Fas in ezrin-knockdown T cells. The expression of Fas, pro-caspase-8 and pro-caspase-3 was similar in control and ezrin-deficient H9 cells (Figure 7a, 0 h ). The expression of cellular FLICE inhibitory protein was also unaffected by ezrin deficiency (Supplementary Figure 3) . We then monitored the biochemical events after Fas ligation. In ezrin-deficient H9 cells, the processing of pro-caspase-8 and the appearance of p43 caspase-8 intermediate were detected earlier than in control H9 cells (Figure 7a ). The accelerated caspase-8 activation in ezrin-knockdown H9 cells was also confirmed by an increase in p18 active caspase-8. This was also accompanied by enhanced proteolysis of pro-caspase-3 and the appearance of active caspase-3 in ezrin-downregulated H9 cells (Figure 7a) . A similar observation was made upon TRAIL treatment of ezrin-deficient H9 cells. TRAIL-triggered cleavage of pro-caspase-8, emergence of active caspase-8 and appearance of active caspase-3 were clearly accelerated in ezrin-knockdown H9 cells, relative to control H9 cells (Supplementary  Figure 4) .
Because caspase-8 activation is the immediate readout of DISC formation, we also measured the extent of DISC formation after Fas ligation. FLAG-tagged FasL was used to pull down DISC. In control H9 cells, Fas engagement resulted in formation of the complex containing Fas, pro-caspase-8 and FADD. The assembly of DISC was greatly enhanced in H9 cells expressing ezrin (1-320) (Figure 7b ) or in H9 cells that were deficient in ezrin (Figure 7c ). Therefore, either ezrin dissociation from cortical actin or ezrin knockdown led to increased overall formation of DISC in H9 cells, resulting in accelerated activation of caspase-8 and caspase-3. 
Deficiency in ezrin enhances Fas-induced apoptosis W-C Kuo et al
Discussion
In this study, we monitored the effect of ezrin deficiency on Fas-mediated cell death. Increased Fas-induced apoptosis caused by ezrin knockdown was found in normal lymphocytes and H9 cells, but not in Jurkat and CEM cells. In contrast to reports that ezrin is essential for Fas-initiated apoptosis (Parlato et al., 2000; Piazzolla et al., 2005; Chakrabandhu et al., 2007; He´bert et al., 2008) , our results support an alternative view that ezrin inactivation and dissociation from actin enhance Fas-induced cell death (Kondo et al., 1997; Ramaswamy et al., 2007) . The opposite results found for the function of ezrin were unlikely to be due to the use of different reagents; the ezrin-specific siRNA used in this study was identical to that used in a recent study illustrating the positive effect of ezrin in Fas-triggered apoptosis in Jurkat cells (He´bert et al., 2008) . In addition, the effect of ezrin knockdown in Fas-induced cell death could be reproduced by the expression of a dominant-negative form of ezrin (Figure 4 ), excluding the possibility that results observed with ezrin-specific siRNA were due to some off-target effect. Ezrin, radixin and moesin (ERM) proteins link the cortical actin cytoskeleton with membrane proteins. How ERM participates in several membrane-associated events in lymphocytes remains unclear. For example, three different roles have been reported for the involvement of ezrin-moesin in immunological synapse (IS) formation: ERM was found to be essential for the assembly of IS and the recruitment of ZAP70 in one group of studies (Roumier et al., 2001; Ilani et al., 2007) ; ezrin was reported to be completely dispensable for IS formation in another study (Shaffer et al., 2009) ; and in yet a third proposal, ezrin was also declared to negatively regulate IS formation (Faure et al., 2004) . Similarly, opposite effects of ERM have been documented for T-lymphocyte movement; T-cell migration could be enhanced by either ERM phosphorylation (Li et al., 2007) or ERM dephosphorylation (Brown et al., 2003) . The negative effect of ezrin in Fas-induced apoptosis presented in this study, in contrast to the previously reported positive role for ezrin, highlights another controversy that is centered on the membrane events involving ERM.
Characterization of the exact involvement of ERM in different cellular events is complicated by the fact that ezrin is interchanged between inactivated and activated forms. Ezrin is present in a phosphorylated form in cells before stimulation through Fas, antigen receptors or chemokine receptors, and is dephosphorylated after these stimulations (Kondo et al., 1997; Delon et al., 2001; Brown et al., 2003; Faure et al., 2004; Gupta et al., 2006; Hao et al., 2009) . Our observation that ezrin was dephosphorylated after FasL stimulation in T cells (Figure 1c ) is in accordance with those reports. Regarding the observation that Fas engagement led to an increased ezrin phosphorylation (He´bert et al., 2008) , we also found that in the later time points of FasL stimulation (>25 min), enhanced ezrin phosphorylation was observed (Figure 1d) . Therefore, FasL treatment leads to an early ezrin inactivation followed by ezrin reactivation, with sequential dephosphorylation and phosphorylation events. However, as ezrin was mostly dissociated from Fas after 20 min (Figure 1b) , the elevated ezrin phosphorylation at later time points after Fas treatment is likely to be irrelevant to the DISC formation and the subsequent apoptosis.
Despite the sequence and structural homology between ezrin and moesin, there are distinct functional differences between these two proteins. One recent example of such differences is the formation of IS in T cells, which involves the opposing actions of ezrin and moesin, with the phosphorylation of ezrin recruiting ZAP70 and the dephosphorylation of moesin removing CD43 (Ilani et al., 2007) . Our observations that knockdown of ezrin, but not of moesin, enhanced Fas-induced apoptosis in H9 cells (Figure 4 ) may represent another functional difference between ezrin and moesin. Whether ezrin and moesin confer distinct restraints on the formation of DISC, or whether Fas is preferentially associated with ezrin, is currently being analysed.
Internalization of Fas is required for efficient DISC formation and caspase-8 activation (Lee et al., 2006; Chakrabandhu et al., 2007) . Ezrin-actin association is reported to be required for endocytosis of Fas in mouse embryonic fibroblasts and L12.10 cells (Piazzolla et al., 2005; Chakrabandhu et al., 2007 Chakrabandhu et al., , 2008 . We found that Fas internalization in H9 cells ( Figure 6 ) was similar in efficiency to that documented elsewhere (Piazzolla et al., 2005; Lee et al., 2006; Chakrabandhu et al., 2007) . However, deficiency in ezrin did not affect endocytosis of Fas in H9 cells, suggesting that the observed enhanced DISC formation (Figure 7) was not due to altered internalization of Fas. Discrepancies in the involvement of ezrin in Fas endocytosis between this study and others (Piazzolla et al., 2005; Chakrabandhu et al., 2007 Chakrabandhu et al., , 2008 may be due to differences between T cells and L cell/fibroblasts, because the function of ERM is highly cell type dependent (Bretscher et al., 2002; Niggli and Rossy, 2008) . However, just why ezrin is required for Fas endocytosis in L cells/fibroblasts but not in T cells remains to be elucidated. Notably, ezrin was associated with Fas in H9 cells, and was disassociated from Fas after FasL treatment (Figure 1b) . In contrast, Fas-ezrin interaction was increased after Fas engagement in L12.10 cells (Chakrabandhu et al., 2007) .
Ezrin-negative regulation was found in normal lymphocytes and H9 cells, but not in type II cells including Jurkat and CEM cells (Figures 2-5) . Type I and type II cells are differentiated mainly by the effectiveness of the DISC assembly (Algeciras-Schimnich et al., 2002; Lee et al., 2006; Feig et al., 2007) . Consistent with the nature of type I cells, FasL treatment led to a high degree of DISC formation in H9 cells, and this was further increased by ezrin knockout or by dominant-negative ezrin (Figure 7) . Because ezrin was not required for internalization of Fas in H9 cells, one possibility is that the association of Fas with ezrin-actin imposes constraints that prevent extensive recruitment of FADD and pro-caspase-8 to assemble DISC, and elimination of the ezrin binding facilitates the early death molecule clustering. On the basis of such a scenario, in type II cells in which only small amounts of DISCs are formed, the involvement of the ezrin-actin network in Fas-initiated apoptotic processes is expected to be minimal, as we have found /ml) were treated with Fas ligand (FasL; 50 ng/ml), cell lysates were prepared at the indicated time points and the levels of pro-caspase-8, pro-caspase-3, active caspase-8, active caspase-3, ezrin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were determined using western blots. (b, c) Increased DISC formation in T cells expressing ezrin (1-320) or with ezrin knockdown. Cell lysates of control and H9 cells expressing ezrin (1-320) (b), or of control and ezrin-knockdown H9 cells (c) were prepared before (0 min) and 25 min after FLAG-FasL stimulation. DISCs in the lysate complexes were pulled down by FLAG-M2 beads. DISC components were eluted from M2 beads by FLAG peptide, and analysed by immunoblots using antibodies specific for Fas, pro-caspse-8, Fas-associated protein with death domain (FADD) and FLAG (for FasL).
with Jurkat and CEM cells ( Figure 5 and Supplementary Figure 2 ). Whether ezrin-dependent inhibition represents another process that differentiates type I cells from type II cells also deserves further analysis.
In summary, the results of this study clearly suggest that ezrin has a negative role in Fas-and TRAILinduced apoptosis in type I T cells, whereby removal of ezrin promotes the endocytosis-independent assembly of DISC. Future works are required to clarify the differential role of ezrin and moesin in death receptormediated apoptosis in type I T cells, and to establish whether the negative regulation of ezrin in Fas-induced cell death is applied to other type of cancer cell. This re-definition of the role of ezrin and cortical actin in Fas-induced apoptosis should help our understanding of the detailed molecular processes of DISC assembly, for effective regulation of death receptor-triggered cell death.
Materials and methods
Reagents
CH11 and anti-tubulin antibodies were purchased from Upstate (Lake Placid, NY, USA). Recombinant human Fas ligand (FLAG-tagged), anti-Fas (Apo-1-3) and anti-cellular FLICE inhibitory protein (NF6) were purchased from Alexis (San Diego, CA, USA). Recombinant human TRAIL was obtained from R&D (Minneapolis, MN, USA). Phycoerythrin-labeled anti-CD95 was purchased from eBioscience (San Diego, CA, USA). Anti-FADD, anti-poly (ADP-ribose) polymerase, anti-ezrin (clone 18), anti-moesin (clone 38) and anti-caspase-8 antibodies were obtained from BD Bioscience (Franklin Lakes, NJ, USA). Horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin and horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulin were obtained from Amersham Bioscience (Buckinghamshire, UK). Anti-caspase-3 (H-277) and anti-FADD (H-181) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-phospho-ERMs (Thr567 of ezrin, Thr564 of radixin and Thr558 of moesin), anti-caspase-8 (1C12), antiactive caspase-8 (Asp391, 18C8) and anti-active caspase-3 (Asp175) were obtained from Cell Signaling (Beverly, MA, USA). Anti-b-tubulin (Clone AA2) was purchased from Upstate.
Glutathione S-transferase (GST) pull-down assay His-tagged ezrin was generated by subcloning the full-length ezrin into pQE-16 vector, and the recombinant His-ezrin was purified on Ni-NTA agarose (both from Qiagen, Hilden, Germany). The C-terminal region (a.a. 185-328) of Fas (Fas-C) was isolated using PCR and was subcloned into pGEX-4T2 (GE Healthcare, Piscataway, NJ, USA) to produce GST fusion protein. Recombinant GST fusion proteins were then purified on glutathione-agarose. A total of 3 mg of GST-Fas-C or GST in glutathione-binding buffer (50 mM potassium phosphate buffer, pH 7.5, 150 mM potassium chloride, 1 mM magnesium chloride, 10% glycerol, 1% Triton X-100, 1% aprotinin and 1 mM phenylmethylsulphonyl fluoride) were loaded on to glutathione-agarose (20 ml, 50% slurry; Sigma, St Louis, MO, USA), and incubated with 3 mg of His-ezrin for 3 h at 4 1C. GST agarose beads were then washed five times with binding buffer, separated by 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis, and detected using anti-His and anti-GST (both from Santa Cruz).
Death-inducing signaling complex (DISC) immunoprecipitation
Aliquots of 4 Â 10 7 H9 cells were incubated with FLAG-FasL (50 ng/ml; Alexis) for the indicated time. Cells were lysed in DISC immunoprecipitation buffer (20 mM Tris-HCl, pH 7.4, 150 mM sodium chloride, 2 mM EDTA, 1% NP-40, 0.25% sodium deoxycholate and protease inhibitors (Roche, Mannheim, Germany)). Cell extracts were immunoprecipitated with FLAG-M2 beads (Sigma) overnight at 4 1C. DISC complexes were eluted from M2 beads by FLAG peptide (0.5 mg/ml). The eluent was resolved using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and probed with anti-ezrin, anti-caspase-8 (BD), anti-FADD, anti-tubulin and anti-FLAG antibodies (Sigma).
Ezrin and moesin knockdown in T leukemia cell lines Ezrin and moesin were knocked down in T leukemia cell lines by two different methods. Jurkat cells (4 Â 10 6 ) were transfected with 500 pmol of ezrin-specific siRNA (Qiagen, 5 0 -AACAGAAACAUUCUGGGCU-3 0 ) and/or the control siRNA (Silencer Cy3-labeled negative control no. 1 siRNA, Ambion, Austin, TX, USA) using electroporation (250 V, 400 mF, Bio-Rad, Hercules, CA, USA). The transfection efficiency, as determined by Cy3 fluorescence, was >85% in all cases. Alternatively, an ezrin-knockdown lentiviral construct was generated by subcloning ezrin-specific short hairpin RNA sequence into pLentiLox vector (pLL3.7, gift of Dr I-Chen Ho, Harvard Medical School, Boston, MA, USA). The sequence of the ezrin-specific short hairpin RNA subcloned was 5 0 -GGACTGATTGAATTACGGA-3 0 , and the sequence of the moesin-specific short hairpin RNA was 5 0 -AGTTC GAGGAACAGACATT-3 0 . Lentiviruses were harvested from culture supernatant of 293FT cells transfected with 20 mg pLL3.7 or pLL3.7-PMLsiRNA, 15 mg psPAX2 and 6 mg pMD2.G. CEM cells were infected with recombinant lentivirus, and green fluorescent protein-expressing cells were isolated using fluorescence sorting 48 h later on a FACSVantage SE (Becton Dickinson, Mountain View, CA, USA). The levels of ezrin and moesin were confirmed using immunoblots.
Knockdown of ezrin in normal human T cells
Human T cells were isolated from peripheral blood using RosetteSep Human T cell Enrichment cocktail (StemCell Technologies, Vancouver, BC, USA) according to the suggested protocol. The purity of CD3 þ T cells was over 97%, as determined using fluorescence-activated cell sorting analysis. T cells were activated by plate-bound anti-CD3 (OKT3, 5 mg/ ml) plus anti-CD28 (clone 37407, 2.5 mg/ml; R&D) for 2 days, and then incubated in the presence of interleukin-2 (10 U/ml; R&D) for an additional 3 days. Transfections of human T cells were performed using the human T cell nucleofector kit (Amaxa, Koeln, Germany). Aliquots of 2 Â 10 7 human T cells were resuspended in 100 ml of human T cell nucleofector solution, mixed with a total of 500 pmol siRNA, and electroporation conducted on a Nucleofector (Amaxa) using program T20. T cells were immediately transferred to prewarmed medium and cultured in complete medium. Cells were used 24 h after transfection for apoptosis induction or immunoblots analysis. The transfection efficiency, as determined by Cy3 fluorescence, was >90% in all cases.
Expression of dominant-negative ezrin Ezrin(1-320)-Myc was sub-cloned into pGC-IRES-YFP (a gift from Dr Gina Costa, Stanford University, Stanford, CA, USA) to generate pGC-ezrin(1-320)-IRES-YFP. Retroviruses were produced by transfection of Phoenix cells (gifts of Dr Garry P Nolan, Stanford University) with 10 mg of pGC-YFP or pGC-ezrin(1-320)-YFP plasmids. Retrovirus-containing super-natants were collected at 48 h after transfection, and were used for spin infection of H9 T cells. At 48 h after infection, YFPexpressing H9 cells were then isolated by sorting on FACSVantage SE (Becton Dickinson). Full-length ezrin-myc was similarly expressed in Jurkat by infection with pGC-F-ezrin. Expression of full-length ezrin-myc (in pcDNA4) in H9 cells was performed by electroporation with an MP-100 (MicroPorator, Digital Bio, Korea) at 1300 V, 30 ms and 1 pulse.
